$2.5 Billion is the total value of Third Security, LLC's 22 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | Buy | INTREXON CORP | $1,873,741,000 | -4.5% | 62,147,301 | +0.7% | 74.88% | -4.1% |
| ZIOP | Buy | ZIOPHARM ONCOLOGY INC | $80,544,000 | -7.5% | 9,692,403 | +0.3% | 3.22% | -7.1% |
| OGEN | Buy | ORAGENICS INC | $19,831,000 | +22.9% | 13,220,225 | +34.4% | 0.79% | +23.4% |
| ETP | Buy | ENERGY TRANSFER PRTNRS L Punit ltd partn | $2,872,000 | -9.9% | 85,135 | +9.7% | 0.12% | -9.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
| TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
| ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
| ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
| NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
| INTREXON CORP | 26 | Q4 2019 | 82.5% |
| ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
| AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
| SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
| ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.